Ruoyu Chen
Chief Financial Officer · GYRE THERAPEUTICS, INC.
Individual
- 2026
- Jan 9, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ruoyu Chen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ruoyu Chen?
Ruoyu Chen is a corporate insider, tracked as Chief Financial Officer of GYRE THERAPEUTICS, INC. (GYRE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ruoyu Chen last file a Form 4?
The only primary Form 4 on record is dated 9 January 2026.